Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00463541 · ClinicalTrials.gov registry record · Phase 3

Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms

A Phase 3 study of Urinary Bladder, Overactive, sponsored by Astellas Pharma.

Completed
Registry status
Phase 3
Development phase
2,225
Enrollment target
20
Study locations

NCT00463541 is a Phase 3 study of Urinary Bladder, Overactive that has completed, run by Astellas Pharma. The registered enrollment target is 2,225 participants, above the 117-participant average among 9 other Urinary Bladder, Overactive trials with a reported enrollment target (1802% higher). The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00463541, a Phase 3 study of Urinary Bladder, Overactive, has completed, sponsored by Astellas Pharma.

COMPLETED
Registry status
Phase 3
Development phase
2,225 participants
Enrollment target
20
Study locations

Study Summary

To evaluate the safety and efficacy of solifenacin succinate in subjects with overactive bladder symptoms (urgency, with or without urge incontinence, usually with frequency and nocturia).

Conditions Studied

Urinary Bladder, Overactive

Interventions

  • DRUG solifenacin succinate

Study Locations (20)

California

  • - Beverly Hills
  • - Buena Park
  • - Corte Madera
  • - Culver City
  • - Fresno
  • - Fullerton
  • - Huntington Beach

Alabama

  • - Bay Minette
  • - Birmingham
  • - Birmingham
  • - Birmingham
  • - Decatur
  • - Huntsville

Arizona

  • - Oro Valley
  • - Phoenix
  • - Phoenix
  • - Scottsdale
  • - Tucson

Arkansas

  • - Little Rock
  • - Little Rock

Trial Details

FieldValue
Enrollment Target 2,225 participants
Start Date 2004-06
Est. Completion 2005-04
Phase Phase 3

Sponsor

Astellas Pharma

165 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00463541

The ClinicalTrials.gov registry entry for NCT00463541 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,225 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 117-participant average among 9 other Urinary Bladder, Overactive trials with a reported enrollment target (1802% higher). The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urinary Bladder, Overactive appearing as the primary indexed condition, and to 1 intervention - of which solifenacin succinate is the first listed.

NCT00463541 reports 20 study locations spanning 4 distinct geographic areas - top geographies include California, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT00463541 about?

NCT00463541 is a clinical study titled "Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms". To evaluate the safety and efficacy of solifenacin succinate in subjects with overactive bladder symptoms (urgency, with or without urge incontinence, usually with frequency and nocturia).

What is the current status of trial NCT00463541?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,225 participants. The study started on 2004-06. Estimated completion is 2005-04.

What conditions does trial NCT00463541 study?

This clinical trial studies the following conditions: Urinary Bladder, Overactive.

What interventions are being tested in trial NCT00463541?

The interventions under investigation include: solifenacin succinate (DRUG).

Who is sponsoring clinical trial NCT00463541?

This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00463541 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Urinary Bladder, Overactive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Urinary Bladder, Overactive

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.